相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Innate Immunity in Hepatitis C Virus Infection
Johannes Schwerk et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus
Isabelle Chemin et al.
HEPATOLOGY (2021)
No Evidence of Hepatitis C Virus (HCV)-Assisted Hepatitis D Virus Propagation in a Large Cohort of HCV-Positive Blood Donors
Pierre Cappy et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Hepatitis delta virus propagation enabled by hepatitis C virus-Scientifically intriguing, but is it relevant to clinical practice?
Lisa Sophie Pflueger et al.
JOURNAL OF VIRAL HEPATITIS (2021)
The changing context of hepatitis D
Mario Rizzetto et al.
JOURNAL OF HEPATOLOGY (2021)
New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
Zhenfeng Zhang et al.
JOURNAL OF HEPATOLOGY (2021)
Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection
Nina Hensel et al.
NATURE IMMUNOLOGY (2021)
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
Wenshi Wang et al.
JOURNAL OF HEPATOLOGY (2021)
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
Michel Bazinet et al.
HEPATOLOGY COMMUNICATIONS (2021)
Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
Eloi R. Verrier et al.
GUT (2020)
Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro-scalable Hepatic Co-culture System
Benjamin Y. Winer et al.
HEPATOLOGY (2020)
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conferences
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2020)
Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
Zhijiang Miao et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
MAIT Cells in Health and Disease
Nicholas M. Provine et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Dulce Alfaiate et al.
JOURNAL OF HEPATOLOGY (2020)
Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication
Natali Abeywickrama-Samarakoon et al.
NATURE COMMUNICATIONS (2020)
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Alexander J. Stockdale et al.
JOURNAL OF HEPATOLOGY (2020)
Current knowledge on Hepatitis Delta Virus replication
Julie Lucifora et al.
ANTIVIRAL RESEARCH (2020)
Animal models for the study of human hepatitis B and D virus infection: New insights and progress
Benjamin J. Burwitz et al.
ANTIVIRAL RESEARCH (2020)
A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study
Christopher Koh et al.
JOURNAL OF HEPATOLOGY (2020)
48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection
Heiner Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2020)
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
Katja Giersch et al.
GUT (2019)
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Hai-Yan Chen et al.
GUT (2019)
Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status
Johanna Landahl et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level
Hadi Karimzadeh et al.
GASTROENTEROLOGY (2019)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer et al.
LANCET INFECTIOUS DISEASES (2019)
Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells
Matthieu Blanchet et al.
ANTIVIRAL RESEARCH (2019)
SAT-202-Endogenous and exogenous IFN responses suppress HDV persistence during proliferation of hepatocytes in vitro
Zhenfeng Zhang et al.
JOURNAL OF HEPATOLOGY (2019)
Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells
Joana Dias et al.
JOURNAL OF HEPATOLOGY (2019)
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients
Alessandro Loglio et al.
JOURNAL OF HEPATOLOGY (2019)
Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation
Florian A. Lempp et al.
NATURE COMMUNICATIONS (2019)
Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus
Yi Ni et al.
SCIENTIFIC REPORTS (2019)
REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection
Andrew Vaillant
ACS INFECTIOUS DISEASES (2019)
Structural Pattern Differences in Unbranched Rod-Like RNA of Hepatitis Delta Virus Affect RNA Editing
Chao-Wei Hsu et al.
VIRUSES-BASEL (2019)
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
Barbara Rehermann et al.
GASTROENTEROLOGY (2019)
Hepatitis D Virus-Specific CD8D+ T Cells Have a Memory-Like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection
Helenie Kefalakes et al.
GASTROENTEROLOGY (2019)
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
Cihan Yurdaydin et al.
JOURNAL OF HEPATOLOGY (2019)
Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set
N. del-Toro et al.
NATURE COMMUNICATIONS (2019)
Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection
Ying Yan et al.
EMERGING MICROBES & INFECTIONS (2019)
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
Lena Allweiss et al.
GUT (2018)
Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection In Vitro
Frauke Beilstein et al.
JOURNAL OF VIROLOGY (2018)
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver
Aleksei Suslov et al.
GASTROENTEROLOGY (2018)
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
Pascal Mutz et al.
GASTROENTEROLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta/lambda responses in hepatocytes
Zhenfeng Zhang et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles
Thomas Tu et al.
JOURNAL OF VIROLOGY (2018)
Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8(+) T Cells
Hadi Karimzadeh et al.
JOURNAL OF VIROLOGY (2018)
Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
Thomas Tu et al.
CURRENT OPINION IN VIROLOGY (2018)
Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics
Sarah Billington et al.
DRUG METABOLISM AND DISPOSITION (2018)
The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells
Thomas Schirdewahn et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Genetic Diversity and Worldwide Distribution of the Deltavirus Genus: A Study of 2,152 Clinical Strains
Frederic Le Gal et al.
HEPATOLOGY (2017)
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis - end of study results from the LOWR HDV-3 study
C. Koh et al.
JOURNAL OF HEPATOLOGY (2017)
A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2017)
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis-end of treatment results from the LOWR HDV-2 study
C. Yurdaydin et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Thomas Tu et al.
VIRUSES-BASEL (2017)
TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation
Dominik Wieland et al.
NATURE COMMUNICATIONS (2017)
Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections
David F. G. Malone et al.
FRONTIERS IN IMMUNOLOGY (2017)
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
Michel Bazinet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes
Dulce Alfaiate et al.
ANTIVIRAL RESEARCH (2016)
Adaptive immunity in HBV infection
Antonio Bertoletti et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Florian A. Lempp et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection
Katja Giersch et al.
JOURNAL OF HEPATOLOGY (2015)
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Christopher Koh et al.
LANCET INFECTIOUS DISEASES (2015)
Effects of HDV infection and pegylated interferon a treatment on the natural killer cell compartment in chronically infected individuals
Sebastian Lunemann et al.
GUT (2015)
Long-term therapy of chronic delta hepatitis with peginterferon alfa
T. Heller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
Benjamin Heidrich et al.
HEPATOLOGY (2014)
Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis
Sebastian Lunemann et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles
Natalia Freitas et al.
JOURNAL OF VIROLOGY (2014)
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation
Ingmar Mederacke et al.
JOURNAL OF HEPATOLOGY (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
E. Snoeck et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
The Pre-S2 Domain of the Hepatitis B Virus Is Dispensable for Infectivity but Serves a Spacer Function for L-Protein-Connected Virus Assembly
Yi Ni et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis Delta Virus Inhibits Alpha Interferon Signaling
Paolo Pugnale et al.
HEPATOLOGY (2009)
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues
Matthieu Blanchet et al.
JOURNAL OF VIROLOGY (2007)
Genomic analysis of the host response to hepatitis B virus infection
S Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus
YH Huang et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Role of CD4 receptor down-regulation during HIV-1 infection
K Levesque et al.
CURRENT HIV RESEARCH (2004)
Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes
KM Breiner et al.
JOURNAL OF VIROLOGY (2001)
分享论文
